Few people from our lab are at the GDAN conference proudly representing the Ding Lab! Thanks to Fernanda for a wonderful presentation.
We were invited to publish a research briefing summarizing the important findings from our recent publication in Nature Genetics (Cui Zhou, D., Jayasinghe, R.G., Chen, S. et al., Nat Genet (2022)). This summary facilitates the communication of our findings to a broader scientific community. Thanks to Nature Genetics for this opportunity!
Welcome our new open access Nature Genetics paper. Dr. Cui Zhou, Dr. Jayasinghe, Dr. Chen and others analyzed spatial heterogeneity of driver events in PDAC, traced transitional cell populations and identified microenvironment cooperation in untreated and chemo-resistant pancreatic cancer. Talented artist Jessica Johnson created a stunning candidate cover image. Too bad it was not selected! WashU news also talked about this high impact paper.
After a long Covid break Steven, Wen-wei and Yige finally attended the graduation ceremony at WashU. Exciting get-together!
Huge congrats to Dr. Yige Wu! Well deserved! Yige is going to stay for couple months as a postdoc to finish her projects. P.S. more pics to come
Thirteen grad students and postdocs represented our lab at the annual AACR 2022 meeting in New Orleans. We are grateful to all opportunities this meeting provides and to Li for supporting us in this endeavor!
Akshay Govindan - a talented undergrad student in our lab - received the Science Education Awards for Undergraduate Students from AACR. We are proud and excited for your next achievements. Plus now Akshay gets to come to AACR 2023 for free.
One of our best computer scientist received his PhD on December 21st 2021! Well deserved, Bobo!
I’m very excited to actually do all the analyses proposed.
Alla
The goal of the research program, called the Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS), is to fill gaps in knowledge to help reduce the disparities seen in rare and understudied cancers that affect underrepresented groups. It will focus on African American patients with colorectal cancer and multiple myeloma, as well as patients of any race or ethnicity with cholangiocarcinoma, a rare cancer of the bile ducts.
The program includes three major units led by investigators with diverse backgrounds and areas of expertise. They are cancer biologist Li Ding, PhD, a professor of medicine in the Division of Oncology and a professor of genetics; cancer epidemiologist Bettina F. Drake, PhD, a professor of surgery in the Division of Public Health Sciences; and surgical oncologist Ryan C. Fields, MD, the Kim and Tim Eberlein Distinguished Professor in the Department of Surgery.
Read more here